ProCE Banner Activity

IMPAACT 2010: Post hoc Analysis of Hypertension in Pregnant Women Initiating DTG + FTC/TAF, DTG + FTC/TDF, or EFV/FTC/TDF

Conference Coverage
Slideset

In this post hoc analysis of the 2010 IMPAACT (VESTED) trial, investigators evaluated the risk of elevated blood pressure and hypertension in ART-naive women initiating DTG + FTC/TAF, DTG + FTC/TDF, or EFV/FTC/TDF during pregnancy and through 50 weeks postpartum.

Released: March 07, 2024

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported through independent educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare